|
FMC Corporation completes sale of peroxygens business to One Equity Partners
Philadelphia, Pennsylvania, USA
March 3, 2014
FMC Corporation (NYSE:FMC) announced today the company has completed the sale of its Peroxygens business to affiliates of One Equity Partners, the private investment arm of J.P. Morgan Chase & Co., for approximately $200 million.
"We're pleased that our former Peroxygens business is now in the capable hands of One Equity Partners where it can grow with focused attention and investment," said Pierre Brondeau, FMC president, CEO and chairman. "This transaction allows FMC to direct its resources to core businesses and its portfolio of advanced technologies."
Citi was FMC's financial advisor for this transaction.
Macquarie Capital was serving as Sole Lead Arranger on the financing for the transaction.
More news from: FMC Corporation
Website: http://www.fmccrop.com Published: March 3, 2014 |
|
The news item on this page is copyright by the organization where it originated
Fair use notice |
Topics
Species
